Clinical trial
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy…
NCT00001810 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001810 |
|---|---|
| Title | An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
| Official title | An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Aspergillosis, Candidiasis, Fungemia, Mycoses |
| Intervention type | Drug |
| Interventions | Voriconazole |
| Enrollment | 300 |
| Start date | Apr 1, 1999 |
| Completion | Oct 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: